Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access

PHASE3CompletedINTERVENTIONAL
Enrollment

710

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
HIV
Interventions
DRUG

Atazanavir

Tablets, Oral, 400 mg, once daily, indefinitely

DRUG

Atazanavir/Ritonavir

Tablets, Oral, 300/100 mg, once daily, indefinitely

DRUG

Tenofovir/Emtricitabine

Tablets, Oral, 300/200 mg, once daily, indefinitely

DRUG

Lopinavir/ritonavir

Tablets, Oral, 400/100 mg, twice daily, indefinitely

Trial Locations (88)

1

Local Institution, Lima

4

Local Institution, Barranco

13

Local Institution, Lima

31

Local Institution, Lima

100

Local Institution, Taipei

108

Local Institution, Taipei

813

Local Institution, Kaohsiung City

1097

Local Institution, Budapest

1155

Local Institution, Buenos Aires

1181

Local Institution, Buenos Aires

1202

Local Institution, Buenos Aires

1610

Local Institution, Meadowdale

1650

Local Institution, Buenos Aires

1792

Local Institution, San José

2000

Local Institution, Rosario

2013

Local Institution, Johannesburg

2092

Local Institution, Westdene

4746

Local Institution, Panama City

6001

Local Institution, Port Elizabeth

7405

Local Institution, Rugby

7925

Local Institution, Observatory

9301

Local Institution, Bloemfontein

10149

Local Institution, Torino

10300

Local Institution, Bangkok

10400

Local Institution, Bangkok

10430

Local Institution, Jakarta

10700

Local Institution, Bangkok

13083

Local Institution, Campinas

14004

Local Institution, Córdoba

14080

Local Institution, Mexico City

20127

Local Institution, Milan

20157

Local Institution, Milan

22271

Local Institution, Rio de Janeiro - Rj

28029

Local Institution, Madrid

28034

Local Institution, Madrid

28040

Local Institution, Madrid

28046

Local Institution, Madrid

28078

Jemsek Clinic, Huntersville

33139

Sbma Research, Llc, Miami Beach

33607

St Josephs Cmprhnsv Rsch Inst, Tampa

41013

Local Institution, Seville

41100

Local Institution, Modena

46218

Infectious Disease Of Indiana, Psc, Indianapolis

48013

Local Institution, Bilbao

50200

Local Institution, Chiang Mai

50586

Local Institution, Kuala Lumpur

52052

Local Institution, Recife

59100

Local Institution, Kuala Lumpur

59208

Local Institution, Tourcoing

67214

Univ Of Kansas Sch Of Med, Wichita

68198

University Of Nebraska Medical Center, Omaha

69288

Local Institution, Lyon

75014

Local Institution, Paris

75020

Local Institution, Paris

76104

Tarrant County Inf Dis Assoc, Fort Worth

77098

The Schrader Clinic, Houston

80060

Local Institution, Curitiba

80240

Local Institution, Curitiba

85006

Phoenix Body Positive, Inc, Phoenix

90033

Rand Schrader Clinic, Los Angeles

94109

St Francis Memorial Hospital, San Francisco

94275

Local Institution, Le Kremlin-Bicêtre

111123

Local Institution, Moscow

189635

Local Institution, Saint Petersburg

193167

Local Institution, Saint Petersburg

308433

Local Institution, Singapore

21040000

Local Institution, Rio de Janeiro

02215

Cri Of New England, Boston

X5000BJH

Local Institution, Córdoba

01246

Local Institution, Sao Paulo - Sp

Local Institution, São Paulo

L8S 4J9

Local Institution, Hamilton

H2L 5B1

Local Institution, Montreal

Unknown

Local Institution, Santiago

Local Institution, Bogota

Local Institution, Santo Domingo

Local Institution, Guatemala City

01011

Local Institution, Guatemala City

01016

Local Institution, Guatemala City

00185

Local Institution, Roma

03100

Local Institution, Mexico City

LIMA 14

Local Institution, Lima

1649-035

Local Institution, Lisbon

4200-319

Local Institution, Porto

00909

Clinical Research Puerto Rico, Inc., San Juan

00927

V.A. Medical Center, San Juan

08915

Local Institution, Badalona

08036

Local Institution, Barcelona

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY